These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 17944456)
1. CoMFA and CoMSIA studies on 1,3-bis(benzylidene)-3,4-dihydro-1H-naphthalen-2-one, 2,6-bis(benzylidene)cyclohexanone, and 3,5-bis(benzylidene)-4-piperidone series of cytotoxic compounds. Patel MR; Dimmock JR; Talele TT J Chem Inf Model; 2007; 47(6):2110-23. PubMed ID: 17944456 [TBL] [Abstract][Full Text] [Related]
2. E,E,E-1-(4-Arylamino-4-oxo-2-butenoyl)-3,5-bis(arylidene)-4-piperidones: a topographical study of some novel potent cytotoxins. Jha A; Mukherjee C; Prasad AK; Parmar VS; Clercq ED; Balzarini J; Stables JP; Manavathu EK; Shrivastav A; Sharma RK; Nienaber KH; Zello GA; Dimmock JR Bioorg Med Chem; 2007 Sep; 15(17):5854-65. PubMed ID: 17562365 [TBL] [Abstract][Full Text] [Related]
3. 3,5-Bis(benzylidene)-4-oxo-1-phosphonopiperidines and related diethyl esters: Potent cytotoxins with multi-drug-resistance reverting properties. Das S; Das U; Selvakumar P; Sharma RK; Balzarini J; De Clercq E; Molnár J; Serly J; Baráth Z; Schatte G; Bandy B; Gorecki DK; Dimmock JR ChemMedChem; 2009 Nov; 4(11):1831-40. PubMed ID: 19802855 [TBL] [Abstract][Full Text] [Related]
4. Development of CoMFA and CoMSIA models of cytotoxicity data of anti-HIV-1-phenylamino-1H-imidazole derivatives. Basu A; Jasu K; Jayaprakash V; Mishra N; Ojha P; Bhattacharya S Eur J Med Chem; 2009 Jun; 44(6):2400-7. PubMed ID: 19000644 [TBL] [Abstract][Full Text] [Related]
6. Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies. Nayana MR; Sekhar YN; Nandyala H; Muttineni R; Bairy SK; Singh K; Mahmood SK J Mol Graph Model; 2008 Oct; 27(3):233-43. PubMed ID: 18676164 [TBL] [Abstract][Full Text] [Related]
7. Three-dimensional quantitative structure activity relationship (3D-QSAR) analysis for in vitro toxicity of chlorophenols to HepG2 cells. Liu Y; Chen JN; Zhao JS; Yu HX; Wang XD; Jiang J; Jin HJ; Zhang JF; Wang LS Chemosphere; 2005 Aug; 60(6):791-5. PubMed ID: 15946721 [TBL] [Abstract][Full Text] [Related]
8. Bis[3,5-bis(benzylidene)-4-oxo-1-piperidinyl]amides: a novel class of potent cytotoxins. Das S; Das U; Varela-Ramírez A; Lema C; Aguilera RJ; Balzarini J; De Clercq E; Dimmock SG; Gorecki DK; Dimmock JR ChemMedChem; 2011 Oct; 6(10):1892-9. PubMed ID: 21826795 [TBL] [Abstract][Full Text] [Related]
9. 3D-QSAR studies on malonyl coenzyme A decarboxylase inhibitors. Patel MR; Talele TT Bioorg Med Chem; 2007 Jul; 15(13):4470-81. PubMed ID: 17482825 [TBL] [Abstract][Full Text] [Related]
10. Molecular modeling of triazine type MDR modulators using CoMFA and CoMSIA approaches. Tsakovska IM; Pajeva IK SAR QSAR Environ Res; 2002; 13(3-4):487-98. PubMed ID: 12184389 [TBL] [Abstract][Full Text] [Related]
11. 3D QSAR studies of 1,3,4-benzotriazepine derivatives as CCK2 receptor antagonists. Kaur K; Talele TT J Mol Graph Model; 2008 Nov; 27(4):409-20. PubMed ID: 18774323 [TBL] [Abstract][Full Text] [Related]
12. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators. Gajjar KA; Gajjar AK Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214 [TBL] [Abstract][Full Text] [Related]
13. 3D QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies of fullerene-based HIV-1 PR inhibitors. Durdagi S; Mavromoustakos T; Papadopoulos MG Bioorg Med Chem Lett; 2008 Dec; 18(23):6283-9. PubMed ID: 18951793 [TBL] [Abstract][Full Text] [Related]
14. Tumour-specific cytotoxicity and structure-activity relationships of novel 1-[3-(2-methoxyethylthio)propionyl]-3,5-bis(benzylidene)-4-piperidones. Hossain M; Das U; Umemura N; Sakagami H; Balzarini J; De Clercq E; Kawase M; Dimmock JR Bioorg Med Chem; 2016 May; 24(10):2206-14. PubMed ID: 27073056 [TBL] [Abstract][Full Text] [Related]
15. Cytotoxic 3,5-bis(benzylidene)piperidin-4-ones and N-acyl analogs displaying selective toxicity for malignant cells. Pati HN; Das U; Quail JW; Kawase M; Sakagami H; Dimmock JR Eur J Med Chem; 2008 Jan; 43(1):1-7. PubMed ID: 17499885 [TBL] [Abstract][Full Text] [Related]
16. Structural investigations of acridine derivatives by CoMFA and CoMSIA reveal novel insight into their structures toward DNA G-quadruplex mediated telomerase inhibition and offer a highly predictive 3D-model for substituted acridines. Zambre VP; Murumkar PR; Giridhar R; Yadav MR J Chem Inf Model; 2009 May; 49(5):1298-311. PubMed ID: 19413274 [TBL] [Abstract][Full Text] [Related]
17. Comparative molecular field analysis of a series of paclitaxel analogues. Zhu Q; Guo Z; Huang N; Wang M; Chu F J Med Chem; 1997 Dec; 40(26):4319-28. PubMed ID: 9435901 [TBL] [Abstract][Full Text] [Related]
18. 3D-QSAR studies on the inhibitors of AP-1 and NF-kappaB mediated transcriptional activation. Qin J; Liu H; Li J; Ren Y; Yao X; Liu M Eur J Med Chem; 2009 Jul; 44(7):2888-95. PubMed ID: 19128859 [TBL] [Abstract][Full Text] [Related]
19. Three-dimensional quantitative structure-activity relationship studies on novel series of benzotriazine based compounds acting as Src inhibitors using CoMFA and CoMSIA. Gueto C; Ruiz JL; Torres JE; Méndez J; Vivas-Reyes R Bioorg Med Chem; 2008 Mar; 16(5):2439-47. PubMed ID: 18065233 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and cytotoxic properties of novel 1-[4-(2-alkylaminoethoxy)phenylcarbonyl]-3,5-bis(arylidene)-4-piperidones and related compounds. Das U; Alcorn J; Shrivastav A; Sharma RK; De Clercq E; Balzarini J; Dimmock JR Eur J Med Chem; 2007 Jan; 42(1):71-80. PubMed ID: 16996657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]